Self support for today’s technological trapsFriday, September 10, 2010 @ 1:54AMStudents may be familiar with the frustrating experience of shouting profanities into the phone once the outsourced tech support finally takes your call. ...
Kim Jong Il Enjoys September ConcertFriday, September 10, 2010 @ 1:52AMPyongyang, September 9 (KCNA) -- General Secretary Kim Jong Il enjoyed the September concert given by Unhasu Orchestra to mark the 62nd anniversary of the founding of the DPRK.
Chip off the old blockFriday, September 10, 2010 @ 12:33AMAs his father’s legacy lingers, defensive tackle Joe Vellano looks to make his own for Terps In Monday's win against Navy, Terrapin defensive tackle Joe Vellano , wearing No. 72, doggedly chased ball-carriers across the field, collecting a career-high 10 tackles and two sacks. ...
Dockers fearless in face of CatsThursday, September 9, 2010 @ 11:54PMBUOYED by their exhilarating season, the young Dockers show no fear, writes Jay Clark.
Alaska program fits vets for construction jobsThursday, September 9, 2010 @ 10:10PMJoseph Todd is a second-year apprentice with the pipefitters union. He is helping to maintain the Trans-Alaska Pipeline System in an area about 280 miles south of Fairbanks.
Stoll has Turpin undefeated againThursday, September 9, 2010 @ 5:50PMTurpin High School football coach and history teacher has the No. 2-ranked Spartans projected to go undefeated this season.
Genetix Pharmaceuticals Appoints Nick Leschly CEOThursday, September 9, 2010 @ 4:06PMCAMBRIDGE, Mass. -- bluebird bio, an emerging leader in the development of innovative gene therapies...
Genetix Pharmaceuticals Renamed bluebird bio Appoints Nick Leschly CEOThursday, September 9, 2010 @ 4:06PMCAMBRIDGE, Mass. -- bluebird bio, an emerging leader in the development of innovative gene therapies...
Genetix Pharmaceuticals Renamed bluebird bio; Announces Appointment of Nick Leschly as Chief Executive OfficerThursday, September 9, 2010 @ 3:42PMCAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, an emerging leader in the development of innovative gene therapies for severe genetic disorders, today announced that it has changed the company name from Genetix Pharmaceuticals, Inc., to bluebird bio, Inc., effective immediately. In addition, bluebird bio has also announced that Nick Leschly, formerly interim president of bluebird bio and ...